Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan
Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Prospective surveillance was conducted from 2009 to 2012 at a com...
Saved in:
Published in | Vaccine Vol. 35; no. 4; pp. 687 - 693 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
23.01.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.
Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.
During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.
Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season. |
---|---|
AbstractList | Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Methods Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. Results During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Conclusions Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season. Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season. Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season. Abstract Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Methods Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. Results During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P < 0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Conclusions Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season. Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season. Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.BACKGROUNDAccumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.METHODSProspective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.RESULTSDuring the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.CONCLUSIONSNegative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season. |
Author | Suzuki, Motoi Saito, Nobuo Kishikawa, Takayuki Yasaka, Takahiro Morimoto, Kounosuke Komori, Kazuhiro Ariyoshi, Koya |
Author_xml | – sequence: 1 givenname: Nobuo surname: Saito fullname: Saito, Nobuo organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan – sequence: 2 givenname: Kazuhiro surname: Komori fullname: Komori, Kazuhiro organization: Kamigoto Hospital, Nagasaki, Japan – sequence: 3 givenname: Motoi surname: Suzuki fullname: Suzuki, Motoi organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan – sequence: 4 givenname: Kounosuke surname: Morimoto fullname: Morimoto, Kounosuke organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan – sequence: 5 givenname: Takayuki surname: Kishikawa fullname: Kishikawa, Takayuki organization: Kamigoto Hospital, Nagasaki, Japan – sequence: 6 givenname: Takahiro surname: Yasaka fullname: Yasaka, Takahiro organization: Kamigoto Hospital, Nagasaki, Japan – sequence: 7 givenname: Koya surname: Ariyoshi fullname: Ariyoshi, Koya email: kari@nagasaki-u.ac.jp organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28043738$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkt9qFDEUxoNU7Lb6CErAG29mTDKTTEZRKcW_FL1QwbuQZs6UrLPJmGQW1tfyBc24WwsLpQuBkPD7vnOS852gI-cdIPSYkpISKp4vy7U2xjooWT6WlJaE1ffQgsqmKhin8ggtCBN1UVPy4xidxLgkhPCKtg_QMZOkrppKLtCfz3Clk10DtqtRm4R9j8dgfcDW9cME7rfG20KZ8g7nZaYQwKVbAL3y7gqP4McBZgRMgg5r12Hn082FdbsyEXT07gU-wwliKtx1O0ZHKIx3KfgBxzR1m1nzSY_aPUT3ez1EeLTbT9H3d2-_nX8oLr68_3h-dlGYhvFUtExqrWXfVFxKSrgWgpuemwpq2bVEyqYXnWyI6FvWG8MENLImRlBSs15c0uoUPdv6jsH_mnJ3amWjgWHQDvwUFZVCVrRp6-oAlHMieC0PQWtRZUsxN_B0D136Kbj85tlQUsFawTP1ZEdNlyvoVP7XlQ4bdT3kDPAtYIKPMUD_H6FEzWFSS7ULk5rDpChVOUxZ93JPZ2z6N-UUtB3uVL_ZqiGPaG0hqGgsOAOdDTkDqvP2TofXew5msM4aPfyEDcSbv1CRKaK-znGf005FRUlDZ4NXtxsc0MBfXbMTrg |
CitedBy_id | crossref_primary_10_1097_EDE_0000000000001116 crossref_primary_10_1016_j_vaccine_2018_04_049 crossref_primary_10_1080_21645515_2020_1826250 crossref_primary_10_1016_j_vaccine_2020_10_074 crossref_primary_10_1016_j_cell_2022_11_012 crossref_primary_10_3390_v14030470 crossref_primary_10_2807_1560_7917_ES_2018_23_7_17_00026 crossref_primary_10_1016_j_vaccine_2017_03_063 crossref_primary_10_1093_cid_ciy202 crossref_primary_10_1080_14760584_2019_1586541 crossref_primary_10_1016_j_toxrep_2020_10_016 crossref_primary_10_1093_cid_ciy327 crossref_primary_10_1371_journal_pone_0198685 crossref_primary_10_1016_j_vaccine_2018_07_052 crossref_primary_10_1038_s41598_023_32537_0 crossref_primary_10_1016_j_vaccine_2023_03_066 crossref_primary_10_1080_21645515_2017_1423152 crossref_primary_10_1093_cid_ciy1009 crossref_primary_10_1021_acsnano_3c06526 crossref_primary_10_1080_14760584_2019_1675519 crossref_primary_10_1101_cshperspect_a038315 crossref_primary_10_11150_kansenshogakuzasshi_94_647 crossref_primary_10_1021_acs_jmedchem_2c01329 crossref_primary_10_1017_S0950268820002058 crossref_primary_10_1111_irv_70089 crossref_primary_10_3390_molecules27227797 crossref_primary_10_3390_vaccines9121447 crossref_primary_10_1016_j_vaccine_2017_06_088 crossref_primary_10_1016_j_vaccine_2018_04_037 crossref_primary_10_1016_j_antinf_2017_05_001 crossref_primary_10_1080_14760584_2019_1622418 crossref_primary_10_1080_14712598_2018_1391786 crossref_primary_10_1038_s41564_023_01505_9 crossref_primary_10_1016_j_vaccine_2018_01_023 crossref_primary_10_3390_v15020374 crossref_primary_10_3390_vaccines8010078 crossref_primary_10_3390_v12050520 crossref_primary_10_1016_S2213_2600_22_00266_1 crossref_primary_10_1080_14760584_2018_1470507 crossref_primary_10_1093_infdis_jiae220 crossref_primary_10_1186_s12979_019_0167_6 crossref_primary_10_3389_fimmu_2023_1133781 crossref_primary_10_1183_16000617_0258_2020 crossref_primary_10_1016_j_vaccine_2021_04_036 crossref_primary_10_1080_21645515_2018_1491246 crossref_primary_10_1038_s41572_018_0002_y crossref_primary_10_1111_irv_12562 |
Cites_doi | 10.1093/cid/cit255 10.2807/ese.18.05.20390-en 10.2807/1560-7917.ES2014.19.6.20701 10.15585/mmwr.mm6430a3 10.1016/S1473-3099(11)70295-X 10.1093/infdis/jiu650 10.1093/ije/dym021 10.1093/cid/cit060 10.1001/jama.1962.03050400013003 10.4049/jimmunol.0900398 10.1093/infdis/jiu651 10.1371/journal.pone.0027622 10.1016/S2213-2600(14)70034-7 10.1093/infdis/jiu580 10.1093/cid/ciw176 10.1016/j.vaccine.2016.01.054 10.1371/journal.pone.0088813 10.1016/S0264-410X(97)00003-0 10.1093/cid/ciu680 10.1371/journal.pmed.1000258 10.1056/NEJMoa0906453 10.1073/pnas.96.24.14001 10.1016/j.vaccine.2007.07.027 10.1093/cid/cis431 10.1371/journal.pone.0052103 10.1093/cid/cit736 10.1371/journal.pmed.1000388 10.1093/cid/cit750 10.1016/j.vaccine.2015.11.077 10.1093/infdis/jiv563 |
ContentType | Journal Article |
Copyright | 2016 The Authors The Authors Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. Copyright Elsevier Limited Jan 23, 2017 |
Copyright_xml | – notice: 2016 The Authors – notice: The Authors – notice: Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: Copyright Elsevier Limited Jan 23, 2017 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7S9 L.6 7X8 |
DOI | 10.1016/j.vaccine.2016.11.024 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | Research Library Prep MEDLINE AGRICOLA MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2518 |
EndPage | 693 |
ExternalDocumentID | 4300730821 28043738 10_1016_j_vaccine_2016_11_024 S0264410X16310714 1_s2_0_S0264410X16310714 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Japan INW, Japan |
GeographicLocations_xml | – name: Japan – name: INW, Japan |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGUBO AGYEJ AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 ROL RPZ SAB SCC SDF SDG SDP SES SNL SPCBC SSH SSI SSZ T5K UKHRP UV1 WH7 WOW Z5R ~G- .GJ 29Q 3V. AACTN AAQXK ABWVN ABXDB ACRPL ADMUD ADNMO ADVLN AFCTW AFJKZ AFKWA AGHFR AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ R2- RIG SAE SEW SIN SVS WUQ XPP ZGI ZXP 6I. AAFTH AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG LCYCR QYZTP AAYXX ACMHX ADSLC AGQPQ AGRNS AGWPP AIGII CITATION CGR CUY CVF ECM EIF NPM 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-c725t-928aaa8f73588105a665cf5c3e48d90887f6d8706f92fcc26e7840c61042f6b13 |
IEDL.DBID | .~1 |
ISSN | 0264-410X 1873-2518 |
IngestDate | Fri Jul 11 04:05:27 EDT 2025 Mon Jul 21 09:46:28 EDT 2025 Fri Jul 11 12:26:52 EDT 2025 Wed Aug 13 11:24:48 EDT 2025 Thu Apr 03 07:01:23 EDT 2025 Thu Apr 24 23:11:04 EDT 2025 Tue Jul 01 01:06:33 EDT 2025 Fri Feb 23 02:21:15 EST 2024 Tue Feb 25 20:03:51 EST 2025 Tue Aug 26 16:40:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Past influenza exposure Repeated vaccination Influenza Vaccine effectiveness |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c725t-928aaa8f73588105a665cf5c3e48d90887f6d8706f92fcc26e7840c61042f6b13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0264410X16310714 |
PMID | 28043738 |
PQID | 1858162965 |
PQPubID | 105530 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1868317943 proquest_miscellaneous_1855065483 proquest_miscellaneous_1846343361 proquest_journals_1858162965 pubmed_primary_28043738 crossref_primary_10_1016_j_vaccine_2016_11_024 crossref_citationtrail_10_1016_j_vaccine_2016_11_024 elsevier_sciencedirect_doi_10_1016_j_vaccine_2016_11_024 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X16310714 elsevier_clinicalkey_doi_10_1016_j_vaccine_2016_11_024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-01-23 |
PublicationDateYYYYMMDD | 2017-01-23 |
PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-23 day: 23 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Kidlington |
PublicationTitle | Vaccine |
PublicationTitleAlternate | Vaccine |
PublicationYear | 2017 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Suzuki, Yoshimine, Harada, Tsuchiya, Shimada, Ariyoshi (b0155) 2013; 8 Ohmit, Thompson, Petrie, Thaker, Jackson, Belongia (b0075) 2014; 58 WHO. Influenza (seasonal): fact sheet number 211; 2014. Ohmit, Petrie, Malosh, Johnson, Truscon, Aaron (b0105) 2016; 213 Grohskopf, Sokolow, Olsen, Bresee, Broder, Karron (b0010) 2015; 64 He, Holmes, Sanyal, Albrecht, Garcia-Sastre, Dekker (b0040) 2015; 211 Kissling, Valenciano, Buchholz, Larrauri, Cohen, Nunes (b0145) 2014; 19 Davenport (b0015) 1962; 182 Castilla, Navascues, Fernandez-Alonso, Reina, Pozo, Casado (b0050) 2016; 34 Ohmit, Petrie, Malosh, Cowling, Thompson, Shay (b0080) 2013; 56 Kissling, Valenciano, Cohen, Oroszi, Barret, Rizzo (b0130) 2011; 6 Thompson, Li, Shifflett, Sokolow, Ferber, Kurosky (b0115) 2014; 58 Keitel, Cate, Couch, Huggins, Hess (b0060) 1997; 15 Kim, Liepkalns, Reber, Lu, Music, Jacob (b0045) 2016; 34 Smith, Forrest, Ackley, Perelson (b0035) 1999; 96 Hancock, Veguilla, Lu, Zhong, Butler, Sun (b0140) 2009; 361 Suzuki, Minh Le, Yoshimine, Inoue, Yoshida, Morimoto (b0095) 2014; 9 Kim, Skountzou, Compans, Jacob (b0085) 2009; 183 Orenstein, De Serres, Haber, Shay, Bridges, Gargiullo (b0150) 2007; 36 [accessed on 28 April 2016]. Valenciano, Kissling, Cohen, Oroszi, Barret, Rizzo (b0125) 2011; 8 McLean, Thompson, Sundaram, Meece, McClure, Friedrich (b0070) 2014; 59 Hayward, Fragaszy, Bermingham, Wang, Copas, Edmunds (b0160) 2014; 2 Carrat, Flahault (b0025) 2007; 25 Kissling, Valenciano, Larrauri, Oroszi, Cohen, Nunes (b0135) 2013; 18 Skowronski, De Serres, Crowcroft, Janjua, Boulianne, Hottes (b0120) 2010; 7 National Institute of Infectious Disease in Japan. Flash report of influenza virus in Japan. Skowronski, Janjua, De Serres, Winter, Dickinson, Gardy (b0020) 2012; 55 Osterholm, Kelley, Sommer, Belongia (b0030) 2012; 12 Sullivan, Kelly (b0065) 2013; 57 Skowronski, Chambers, Sabaiduc, De Serres, Winter, Dickinson (b0055) 2016; 63 Neuzil (b0090) 2015; 211 Ohmit, Petrie, Malosh, Fry, Thompson, Monto (b0100) 2015; 211 Osterholm (10.1016/j.vaccine.2016.11.024_b0030) 2012; 12 Castilla (10.1016/j.vaccine.2016.11.024_b0050) 2016; 34 Kissling (10.1016/j.vaccine.2016.11.024_b0135) 2013; 18 Skowronski (10.1016/j.vaccine.2016.11.024_b0020) 2012; 55 Skowronski (10.1016/j.vaccine.2016.11.024_b0055) 2016; 63 Ohmit (10.1016/j.vaccine.2016.11.024_b0080) 2013; 56 10.1016/j.vaccine.2016.11.024_b0110 Kissling (10.1016/j.vaccine.2016.11.024_b0130) 2011; 6 Sullivan (10.1016/j.vaccine.2016.11.024_b0065) 2013; 57 Hancock (10.1016/j.vaccine.2016.11.024_b0140) 2009; 361 Kim (10.1016/j.vaccine.2016.11.024_b0045) 2016; 34 Skowronski (10.1016/j.vaccine.2016.11.024_b0120) 2010; 7 He (10.1016/j.vaccine.2016.11.024_b0040) 2015; 211 Hayward (10.1016/j.vaccine.2016.11.024_b0160) 2014; 2 Valenciano (10.1016/j.vaccine.2016.11.024_b0125) 2011; 8 Suzuki (10.1016/j.vaccine.2016.11.024_b0155) 2013; 8 Davenport (10.1016/j.vaccine.2016.11.024_b0015) 1962; 182 Ohmit (10.1016/j.vaccine.2016.11.024_b0105) 2016; 213 Smith (10.1016/j.vaccine.2016.11.024_b0035) 1999; 96 Grohskopf (10.1016/j.vaccine.2016.11.024_b0010) 2015; 64 Kissling (10.1016/j.vaccine.2016.11.024_b0145) 2014; 19 Ohmit (10.1016/j.vaccine.2016.11.024_b0075) 2014; 58 Thompson (10.1016/j.vaccine.2016.11.024_b0115) 2014; 58 Neuzil (10.1016/j.vaccine.2016.11.024_b0090) 2015; 211 McLean (10.1016/j.vaccine.2016.11.024_b0070) 2014; 59 10.1016/j.vaccine.2016.11.024_b0005 Orenstein (10.1016/j.vaccine.2016.11.024_b0150) 2007; 36 Suzuki (10.1016/j.vaccine.2016.11.024_b0095) 2014; 9 Ohmit (10.1016/j.vaccine.2016.11.024_b0100) 2015; 211 Kim (10.1016/j.vaccine.2016.11.024_b0085) 2009; 183 Carrat (10.1016/j.vaccine.2016.11.024_b0025) 2007; 25 Keitel (10.1016/j.vaccine.2016.11.024_b0060) 1997; 15 |
References_xml | – volume: 55 start-page: 332 year: 2012 end-page: 342 ident: b0020 article-title: A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season publication-title: Clin Infect Dis – volume: 36 start-page: 623 year: 2007 end-page: 631 ident: b0150 article-title: Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness publication-title: Int J Epidemiol – volume: 182 start-page: 11 year: 1962 end-page: 13 ident: b0015 article-title: Current knowledge of influenza vaccine publication-title: JAMA – volume: 58 start-page: 449 year: 2014 end-page: 457 ident: b0115 article-title: Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 and 2011–2012 influenza seasons publication-title: Clin Infect Dis – volume: 58 start-page: 319 year: 2014 end-page: 327 ident: b0075 article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates publication-title: Clin Infect Dis – volume: 7 start-page: e1000258 year: 2010 ident: b0120 article-title: Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada publication-title: PLoS Med – volume: 6 year: 2011 ident: b0130 article-title: I-move multi-centre case control study 2010–11: overall and stratified estimates of influenza vaccine effectiveness in Europe publication-title: PLoS ONE – volume: 57 start-page: 474 year: 2013 end-page: 476 ident: b0065 article-title: Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required publication-title: Clin Infect Dis – volume: 12 start-page: 36 year: 2012 end-page: 44 ident: b0030 article-title: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis publication-title: Lancet Infect Dis – volume: 211 start-page: 1517 year: 2015 end-page: 1518 ident: b0090 article-title: How can we solve the enigma of influenza vaccine-induced protection? publication-title: J Infect Dis – volume: 8 start-page: e52103 year: 2013 ident: b0155 article-title: Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan publication-title: PLoS ONE – reference: National Institute of Infectious Disease in Japan. Flash report of influenza virus in Japan. – volume: 361 start-page: 1945 year: 2009 end-page: 1952 ident: b0140 article-title: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus publication-title: N Engl J Med – volume: 64 start-page: 818 year: 2015 end-page: 825 ident: b0010 article-title: Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2015–16 influenza season publication-title: MMWR Morb Mortal Wkly Rep – volume: 15 start-page: 1114 year: 1997 end-page: 1122 ident: b0060 article-title: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period publication-title: Vaccine – volume: 8 start-page: e1000388 year: 2011 ident: b0125 article-title: Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study publication-title: PLoS Med – volume: 34 start-page: 1350 year: 2016 end-page: 1357 ident: b0050 article-title: Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons publication-title: Vaccine – volume: 211 start-page: 1051 year: 2015 end-page: 1059 ident: b0040 article-title: Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination publication-title: J Infect Dis – volume: 19 start-page: 20701 year: 2014 ident: b0145 article-title: Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13 publication-title: Euro Surveill – volume: 34 start-page: 495 year: 2016 end-page: 502 ident: b0045 article-title: Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains publication-title: Vaccine – volume: 9 start-page: e88813 year: 2014 ident: b0095 article-title: Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011–2012 season publication-title: PLoS ONE – volume: 63 start-page: 21 year: 2016 end-page: 32 ident: b0055 article-title: A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season publication-title: Clin Infect Dis – volume: 18 year: 2013 ident: b0135 article-title: Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study publication-title: Euro Surveill – reference: WHO. Influenza (seasonal): fact sheet number 211; 2014. – volume: 183 start-page: 3294 year: 2009 end-page: 3301 ident: b0085 article-title: Original antigenic sin responses to influenza viruses publication-title: J Immunol – reference: [accessed on 28 April 2016]. – volume: 56 start-page: 1363 year: 2013 end-page: 1369 ident: b0080 article-title: Influenza vaccine effectiveness in the community and the household publication-title: Clin Infect Dis – volume: 2 start-page: 445 year: 2014 end-page: 454 ident: b0160 article-title: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study publication-title: Lancet Respir Med – volume: 59 start-page: 1375 year: 2014 end-page: 1385 ident: b0070 article-title: Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons publication-title: Clin Infect Dis – volume: 96 start-page: 14001 year: 1999 end-page: 14006 ident: b0035 article-title: Variable efficacy of repeated annual influenza vaccination publication-title: Proc Natl Acad Sci USA – volume: 213 start-page: 1229 year: 2016 end-page: 1236 ident: b0105 article-title: Substantial influenza vaccine effectiveness in households with children during the 2013–2014 influenza season, when 2009 Pandemic influenza A(H1N1) virus predominated publication-title: J Infect Dis – volume: 211 start-page: 1519 year: 2015 end-page: 1528 ident: b0100 article-title: Influenza vaccine effectiveness in households with children during the 2012–2013 season: assessments of prior vaccination and serologic susceptibility publication-title: J Infect Dis – volume: 25 start-page: 6852 year: 2007 end-page: 6862 ident: b0025 article-title: Influenza vaccine: the challenge of antigenic drift publication-title: Vaccine – volume: 57 start-page: 474 issue: 3 year: 2013 ident: 10.1016/j.vaccine.2016.11.024_b0065 article-title: Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required publication-title: Clin Infect Dis doi: 10.1093/cid/cit255 – volume: 18 issue: 5 year: 2013 ident: 10.1016/j.vaccine.2016.11.024_b0135 article-title: Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study publication-title: Euro Surveill doi: 10.2807/ese.18.05.20390-en – volume: 19 start-page: 20701 issue: 6 year: 2014 ident: 10.1016/j.vaccine.2016.11.024_b0145 article-title: Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES2014.19.6.20701 – volume: 64 start-page: 818 issue: 30 year: 2015 ident: 10.1016/j.vaccine.2016.11.024_b0010 article-title: Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2015–16 influenza season publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6430a3 – ident: 10.1016/j.vaccine.2016.11.024_b0110 – volume: 12 start-page: 36 issue: 1 year: 2012 ident: 10.1016/j.vaccine.2016.11.024_b0030 article-title: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(11)70295-X – ident: 10.1016/j.vaccine.2016.11.024_b0005 – volume: 211 start-page: 1519 issue: 10 year: 2015 ident: 10.1016/j.vaccine.2016.11.024_b0100 article-title: Influenza vaccine effectiveness in households with children during the 2012–2013 season: assessments of prior vaccination and serologic susceptibility publication-title: J Infect Dis doi: 10.1093/infdis/jiu650 – volume: 36 start-page: 623 issue: 3 year: 2007 ident: 10.1016/j.vaccine.2016.11.024_b0150 article-title: Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness publication-title: Int J Epidemiol doi: 10.1093/ije/dym021 – volume: 56 start-page: 1363 issue: 10 year: 2013 ident: 10.1016/j.vaccine.2016.11.024_b0080 article-title: Influenza vaccine effectiveness in the community and the household publication-title: Clin Infect Dis doi: 10.1093/cid/cit060 – volume: 182 start-page: 11 issue: 1 year: 1962 ident: 10.1016/j.vaccine.2016.11.024_b0015 article-title: Current knowledge of influenza vaccine publication-title: JAMA doi: 10.1001/jama.1962.03050400013003 – volume: 183 start-page: 3294 issue: 5 year: 2009 ident: 10.1016/j.vaccine.2016.11.024_b0085 article-title: Original antigenic sin responses to influenza viruses publication-title: J Immunol doi: 10.4049/jimmunol.0900398 – volume: 211 start-page: 1517 issue: 10 year: 2015 ident: 10.1016/j.vaccine.2016.11.024_b0090 article-title: How can we solve the enigma of influenza vaccine-induced protection? publication-title: J Infect Dis doi: 10.1093/infdis/jiu651 – volume: 6 issue: 11 year: 2011 ident: 10.1016/j.vaccine.2016.11.024_b0130 article-title: I-move multi-centre case control study 2010–11: overall and stratified estimates of influenza vaccine effectiveness in Europe publication-title: PLoS ONE doi: 10.1371/journal.pone.0027622 – volume: 2 start-page: 445 issue: 6 year: 2014 ident: 10.1016/j.vaccine.2016.11.024_b0160 article-title: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(14)70034-7 – volume: 211 start-page: 1051 issue: 7 year: 2015 ident: 10.1016/j.vaccine.2016.11.024_b0040 article-title: Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination publication-title: J Infect Dis doi: 10.1093/infdis/jiu580 – volume: 63 start-page: 21 issue: 1 year: 2016 ident: 10.1016/j.vaccine.2016.11.024_b0055 article-title: A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season publication-title: Clin Infect Dis doi: 10.1093/cid/ciw176 – volume: 34 start-page: 1350 issue: 11 year: 2016 ident: 10.1016/j.vaccine.2016.11.024_b0050 article-title: Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons publication-title: Vaccine doi: 10.1016/j.vaccine.2016.01.054 – volume: 9 start-page: e88813 issue: 2 year: 2014 ident: 10.1016/j.vaccine.2016.11.024_b0095 article-title: Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011–2012 season publication-title: PLoS ONE doi: 10.1371/journal.pone.0088813 – volume: 15 start-page: 1114 issue: 10 year: 1997 ident: 10.1016/j.vaccine.2016.11.024_b0060 article-title: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period publication-title: Vaccine doi: 10.1016/S0264-410X(97)00003-0 – volume: 59 start-page: 1375 issue: 10 year: 2014 ident: 10.1016/j.vaccine.2016.11.024_b0070 article-title: Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons publication-title: Clin Infect Dis doi: 10.1093/cid/ciu680 – volume: 7 start-page: e1000258 issue: 4 year: 2010 ident: 10.1016/j.vaccine.2016.11.024_b0120 article-title: Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada publication-title: PLoS Med doi: 10.1371/journal.pmed.1000258 – volume: 361 start-page: 1945 issue: 20 year: 2009 ident: 10.1016/j.vaccine.2016.11.024_b0140 article-title: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus publication-title: N Engl J Med doi: 10.1056/NEJMoa0906453 – volume: 96 start-page: 14001 issue: 24 year: 1999 ident: 10.1016/j.vaccine.2016.11.024_b0035 article-title: Variable efficacy of repeated annual influenza vaccination publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.24.14001 – volume: 25 start-page: 6852 issue: 39–40 year: 2007 ident: 10.1016/j.vaccine.2016.11.024_b0025 article-title: Influenza vaccine: the challenge of antigenic drift publication-title: Vaccine doi: 10.1016/j.vaccine.2007.07.027 – volume: 55 start-page: 332 issue: 3 year: 2012 ident: 10.1016/j.vaccine.2016.11.024_b0020 article-title: A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season publication-title: Clin Infect Dis doi: 10.1093/cid/cis431 – volume: 8 start-page: e52103 issue: 1 year: 2013 ident: 10.1016/j.vaccine.2016.11.024_b0155 article-title: Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan publication-title: PLoS ONE doi: 10.1371/journal.pone.0052103 – volume: 58 start-page: 319 issue: 3 year: 2014 ident: 10.1016/j.vaccine.2016.11.024_b0075 article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates publication-title: Clin Infect Dis doi: 10.1093/cid/cit736 – volume: 8 start-page: e1000388 issue: 1 year: 2011 ident: 10.1016/j.vaccine.2016.11.024_b0125 article-title: Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study publication-title: PLoS Med doi: 10.1371/journal.pmed.1000388 – volume: 58 start-page: 449 issue: 4 year: 2014 ident: 10.1016/j.vaccine.2016.11.024_b0115 article-title: Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 and 2011–2012 influenza seasons publication-title: Clin Infect Dis doi: 10.1093/cid/cit750 – volume: 34 start-page: 495 issue: 4 year: 2016 ident: 10.1016/j.vaccine.2016.11.024_b0045 article-title: Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains publication-title: Vaccine doi: 10.1016/j.vaccine.2015.11.077 – volume: 213 start-page: 1229 issue: 8 year: 2016 ident: 10.1016/j.vaccine.2016.11.024_b0105 article-title: Substantial influenza vaccine effectiveness in households with children during the 2013–2014 influenza season, when 2009 Pandemic influenza A(H1N1) virus predominated publication-title: J Infect Dis doi: 10.1093/infdis/jiv563 |
SSID | ssj0005319 |
Score | 2.4279537 |
Snippet | Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies... Abstract Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no... Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 687 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Allergy and Immunology Case studies Case-Control Studies Child Child, Preschool Confidence intervals Data analysis Diagnostic tests Epidemics experimental design Female Health insurance Hospitals Hospitals, Community Humans Infant Infant, Newborn Infections Influenza Influenza Vaccines - administration & dosage Influenza Vaccines - immunology Influenza, Human - epidemiology Influenza, Human - immunology Influenza, Human - prevention & control Japan Japan - epidemiology Local government Male Middle Aged monitoring odds ratio Past influenza exposure Patients people Population Prospective Studies Repeated vaccination risk Seasons Treatment Outcome vaccination Vaccine effectiveness Vaccines Young Adult |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZgCMQLgvKrMJCR0J7mLrEdx-UFTYhpmrRpEhvqm-U49tQJJaXNkMa_xT-Iz3aaF9oh5anxyUl9ufvOvvsOoY8uo04LNyU0NzXhtbZEl1VNpC2N4UILqSFQPD0Tx5f8ZFbM0obbKqVV9jYxGOq6NbBHfuD9iswFnYri8-Inga5RcLqaWmjcRw-Augy0upyVQ4oHC409fJjBCc-z2VDBc3A9-aUNHF1DdpeYAJEn5Zt80ybsGXzQ0VP0JIFHfBhX-xm6Z5sRehjbSd6O0KPTdFA-QnvnkZL6dh9fDBVWq328h88HsmovM_oO-TChKBf34s_RnzN7FRjBcayixK3Di-W8XeJ5bGryW-P4ZmFhsb9MJHraMCD0NMIxXR3HBDBbY93UuGm74Yd5k6aBrcu2-YQPsYfCHWn6xzHe6ZKUXo8DNS7InHiP37xAl0dfL74ck9TegZiSFh2ZUqm1lq5khZQe5mkhCuMKwyyXNaRflU7UcAzrptQZQ4UtfTRqPN7j1IkqZy_RTtM29jXCxmkJzduFFQW3lZbSyYpzO5VcVhUTY8T7hVUmcZ9DC44fqk9yu1ZJHxTog4-LlNeHMZqsxRaR_OMuAdFrjeorW70tVt493SVY_kvQrpJFWalcrajK1LcsINhs5nF0DsVnYyTXkgk0RTD0P5Pu9oqthnnW39kYfVjf9jYHDpJ0Y9sbGMMF44yJfNsYH_v61ZBs2xghWaAoHKNX8cNa_89URtatN9sf8i16TAFoZTmhbBftdMsb-87DxK56H2zBXxj-agU priority: 102 providerName: ProQuest |
Title | Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X16310714 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X16310714 https://dx.doi.org/10.1016/j.vaccine.2016.11.024 https://www.ncbi.nlm.nih.gov/pubmed/28043738 https://www.proquest.com/docview/1858162965 https://www.proquest.com/docview/1846343361 https://www.proquest.com/docview/1855065483 https://www.proquest.com/docview/1868317943 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemIRAvCMpXx0BGQnua28R2HIe3Um0qQ6sq2FDfLMexUSeUVG03aTzwT_EP4q-0IOiGkKIkSu5kJ77cneO73wHwxiTYSGYKhFNVIVpJjWReVojrXCnKJOPSTRRPx2x0Tk-m2XQHDNtcGBdWGXV_0OleW8cr_fg2-_PZrP8p8bY8mVqPInVpOC6DneZOynvffwnzIL64hyNGjnqTxdO_6F1J5ZavXYQX6zkwT0y32adt_qe3Q8cPwYPoQMJB6OMjsKPrDrgbSkped8C907hY3gEHkwBLfX0IzzZZVstDeAAnG8Bqy9P57GJifGIubNkfgx9j_cWjgsOQSQkbA-eLWbOAs1DY5JuE4cn84EK7qQD2tIXA1zWCIWQdhiAwXUFZV7BuVpsLszo2435fNvVbOIDWHV6huu2OsoYXxRB76OFxHc-Jtfr1E3B-fHQ2HKFY4gGpHGcrVGAupeQmJxnn1tWTjGXKZIpoyisXgpUbVrmlWFNgoxRmOrczUmV9PooNK1PyFOzWTa2fA6iM5K6AO9Mso7qUnBteUqoLTnlZEtYFtB1YoSL-uSvD8VW0gW4XIsqDcPJg50bCykMX9NZs8wAAchsDa6VGtNmtVh8La6JuY8z_xqiXUassRSqWWCTiD8nvAr7m_O3j-ZdG91vBFpt2eMZThguWdcHr9W2rd9xikqx1c-loKCOUEJbeRGPnv3Y0OLmJhnHiYQq74Fn4sNbvGfOAvLX3_8_3AtzHzhFLUoTJPthdLS71S-tGrspXXk_YfT7N7Z4P7fmdwfsPo7E9vjsaTz7-BCgqeO0 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEB8vCMpXYICRYE9zlziO4yIhNA2m7qPVJDrUN-M4NuqEktJ2oPJH8cI_yDlOWh5ox8ukPqW-OK3P59_l7n6H0CsbUqu47RAa6ZywXBmi0iwnwqRaM664UM5R7PV594wdDZPhBvrV1MK4tMrGJlaGOi-1e0e-C-eKiDjt8OTd-BtxXaNcdLVpoeHV4tjMf4DLNn17-B7W9zWlBx8G-11SdxUgOqXJjHSoUEoJm8aJEIAuFOeJtomODRO5y_pJLc9d9M92qNWacpOCE6QBZjBqeRbFcN9r6DqLYWu6yvT9v1JK4qqRCLg1jLAoHC4rhnbP29-VdqFyl03G2444lLJVZ-EqrFudeQd30Z0arOI9r1330IYpWuiGb185b6GbvTow30Lbp54Ce76DB8uKrukO3sanS3JskGl9cvk3VREwbsTvo99986ViIMe-ahOXFo8no3KCR76Jyk-F_S-rFAnDR3tiqRUDqh5K2KfHY59wZnKsihwX5Wx5YVTU07hXpWXxBu9hgN4zUjSPo-GQJ3U6P66oeJ3MESCM4gE6u5KFf4g2i7IwjxHWVgnXLJ4bnjCTKSGsyBgzHcFElsU8QKxZWKlrrnXX8uOrbJLqzmWtD9LpA_hhEvQhQO2F2NiTjVwmwButkU0lLdh-CcfhZYLpvwTNtLZgUxnJKZWh_BhWiDkcAm6PXLFbgMRCsgZpHnz9z6RbjWLL5TyLfR2gl4uvwca5wJUqTHnhxjAew4bj0box4GvDaoh43Rgu4ooSMUCP_MZa_M9UeJavJ-sf8gW61R30TuTJYf_4KbpNHcgLI0LjLbQ5m1yYZwBRZ9nzyi5g9PmqDdEf-jSlPA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEBMvCMpXYYCRYE9z29iO4yIhNG1U-2BVJTbUN-M4NuqEktJ2oPJv8cZfxzlOWh5ox8ukPqW-OK3Pd7-Lf3eH0CvXoU4L1yU0MhnhmbZEJ2lGpE2M4UILqX2geNoXh-f8eBgPN9DvOhfG0yprm1ga6qww_h15G_yKjATtirjtKlrE4KD3bvyN-A5S_qS1bqcRVOTEzn9A-DZ9e3QAa_2a0t77s_1DUnUYICah8Yx0qdRaS5ewWEpAGlqI2LjYMMtl5hlAiROZPwl0XeqMocImEBAZgBycOpFGDO57A91MWCL9HpP7f9FLWNlUBEIcTnjUGS6zh9oXre_a-GNzzywTLV9ElPJVfnEV7i39X-8uulMBV7wXNO0e2rB5A90KrSznDbR1Wh3SN9DOIJTDnu_is2V213QX7-DBslA2yDQ-eS5OmRCMa_H76FfffimrkeOQwYkLh8eTUTHBo9BQ5afG4ZeVSoXhY0KRqRUDyn5KOFDlcSCf2QzrPMN5MVteGOXVNP61aZG_wXsYYPiM5PXjGHD4pKL247Isr5c5BrSRP0Dn17LwD9FmXuT2McLGaekbxwsrYm5TLaWTKee2K7lMUyaaiNcLq0xVd923__iqaoLdhar0QXl9gJhMgT40UWshNg6FR64SELXWqDqrFvyAAtd4lWDyL0E7razZVEVqSlVHfeyU6LkzBAwf-cS3JpILyQqwBSD2P5Nu14qtlvMs9ngTvVx8DfbOH2Lp3BaXfgwXjDMmonVjIO6G1ZBs3RghWVkesYkehY21-J-pDBW_nqx_yBdoC0yQ-nDUP3mKblOP9zoRoWwbbc4ml_YZoNVZ-rw0Cxh9vm479AfJj6ly |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Negative+impact+of+prior+influenza+vaccination+on+current+influenza+vaccination+among+people+infected+and+not+infected+in+prior+season%3A+A+test-negative+case-control+study+in+Japan&rft.jtitle=Vaccine&rft.au=Saito%2C+Nobuo&rft.au=Komori%2C+Kazuhiro&rft.au=Suzuki%2C+Motoi&rft.au=Morimoto%2C+Kounosuke&rft.date=2017-01-23&rft.issn=0264-410X&rft.volume=35&rft.issue=4&rft.spage=687&rft.epage=693&rft_id=info:doi/10.1016%2Fj.vaccine.2016.11.024&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0264-410X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0264-410X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0264-410X&client=summon |